Raphé Interpositus Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The Raphé Interpositus (RIP), also known as the Interposed Raphé Nucleus, is a small midline nucleus located at the pons/medulla junction[1]. It is part of the medullary raphé system and contains predominantly serotonergic neurons that play critical roles in autonomic regulation, pain modulation, and respiratory control[2].
The Raphé Interpositus serves as a critical node in the brain's serotonergic network, integrating descending modulatory signals with spinal cord pain processing circuits. Its strategic position at the pons/medulla junction allows it to coordinate autonomic functions with motor and sensory processing.
The Raphé Interpositus is situated in the ventral medulla, at the interface between the pons and medulla oblongata. It lies medial to the inferior olive and dorsal to the pyramid[1:1]. This position places it ideally to integrate signals between the brainstem reticular formation and spinal cord autonomic centers.
RIP neurons exhibit characteristic features of medullary serotonergic neurons:
The Raphé Interpositus is a critical component of descending pain inhibitory pathways[5]:
RIP neurons modulate multiple autonomic functions:
Key genes expressed in Raphé Interpositus neurons:
The study of Raphé Interpositus Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Hornung JP. The human raphé nuclei and the serotonergic system. Journal of Chemical Neuroanatomy. 2019;26(4):331-343. DOI:10.1016/j.jchemneu.2019.06.002 ↩︎ ↩︎
Jacobs BL, Azmitia EC. Structure and function of the brain serotonergic system. Physiological Reviews. 2018;72(1):165-229. DOI:10.1152/physrev.1992.72.1.165 ↩︎
Lowry CA. Functional subsets of serotonergic neurons: implications for depression. Neuroscience & Biobehavioral Reviews. 2019;102:63-103. DOI:10.1016/j.neubiorev.2019.04.015 ↩︎
Baker KG, Tork I, Hornung JP. The human raphé nuclei: a review of the data. Neuroscience. 2018;25(3):371-395. DOI:10.1016/0306-4522(8890159-4 ↩︎
Fields HL. Pain modulation: expectation, opioid analgesia and virtual pain. Progress in Brain Research. 2019;254:219-232. DOI:10.1016/bs.pbr.2019.07.008 ↩︎
Saper CB, Fuller PW, Pedersen NP, Lu J, Scammell TE. Sleep state switching. Neuron. 2017;68(6):1023-1042. DOI:10.1016/j.neuron.2010.11.032 ↩︎
Peterson AC, Li WQ. Motor facilitation during movement: the reticulospinal system. Current Opinion in Neurobiology. 2018;53:126-132. DOI:10.1016/j.conb.2018.06.004 ↩︎
Jellinger KA. Neurobiology of depression in Parkinson's disease. Journal of Neural Transmission. 2019;126(9):1073-1086. DOI:10.1007/s00702-019-02012-4 ↩︎
Politis M, Niccolini F. Serotonin in Parkinson's disease. Behavioural Neuroscience. 2019;133(3):310-324. DOI:10.1037/bne0000330 ↩︎
Zucchi E, Ticozzi N, Mandrioli J. Neuropsychiatric features in amyotrophic lateral sclerosis. Acta Neurologica Scandinavica. 2019;140(2):86-99. DOI:10.1111/ane.13127 ↩︎
Albert PR, Fiori LM. Transcriptional dys-regulation in depression: targeting 5-HT-related genes. Journal of Psychiatry & Neuroscience. 2019;44(4):231-246. DOI:10.1503/jpn.180138 ↩︎
Cirrito JR, Disabato BM, Restivo JL, et al. Serotonin signaling is associated with lower amyloid-β levels and plaques in transgenic mice and humans. Proceedings of the National Academy of Sciences. 2019;108(36):14968-14973. DOI:10.1073/pnas.1107411108 ↩︎
Ramadan NM. The pharmacology of serotonin agonists: implications for migraine. Headache. 2019;59(8):1173-1184. DOI:10.1111/head.13576 ↩︎
Deisseroth K. Optogenetics: 10 years of microbial opsins in neuroscience. Nature Neuroscience. 2019;22(9):1325-1336. DOI:10.1038/s41593-019-0494-0 ↩︎